Clinical Trial Detail

NCT ID NCT01842646
Title Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Glasdegib

Age Groups: adult

No variant requirements are available.